Company intelligence / Profile preview

Tibet Aim Pharm

Beijing, Beijing, Chinaemyy.cn ↗

Ownership: Private
Development stage: Commercial

Overview

Tibet Aim Pharm is a publicly listed pharmaceutical company in China with a broad portfolio of marketed drugs including small molecules and traditional Chinese medicines. Its product line covers metabolic diseases (diabetes), cardiovascular conditions, women’s health/obstetrics, gastroenterology/digestive health, pain/inflammation management as well as emergency antidotes for poisoning. The company is active in R&D but specific late-stage pipeline assets are not detailed in public sources.

Therapeutic areas: EndocrinologyOtherGastroenterologyCardiovascularWomen's Health
Modalities: Small moleculesPeptides/hormonesTraditional Chinese medicine formulations
Industry: Biotech

Drug pipeline

1 asset

Azithromycin (Tibet Aim Pharm)

Unknown

Beyond the preview

Go deeper on Tibet Aim Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tibet Aim Pharm.

Explore the full profile